Literature DB >> 29702842

Economic Burden of Individual Suffering from Atrial Fibrillation-Related Stroke in China.

Shanlian Hu1, Lin Zhan2, Bao Liu3, Yue Gao4, Yan Li5, Rongsheng Tong6, Lin Wu7, Bo Yu8, Shen Gao9.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) is an important risk factor for stroke. The primary purpose of this study was to estimate the 1-year direct and indirect costs of ischemic stroke in Chinese patients with AF.
METHOD: A total of 300 charts were selected and reviewed in 18 hospitals from neurology departments in six major cities of China nationwide. Patients with primary diagnosis of ischemic stroke and secondary diagnosis of AF were selected for review. A total of 63 patients were selected from the chart review pool and followed up for 1 year to record their resource utilization and absenteeism from work following discharge.
RESULTS: The mean±SD age of the cohort was 70.2±11.8 years, with an average hospitalization duration of stay of 17.9 days. The mean total direct cost for AF-related stroke was estimated at 30,438.3 China Yuan (CNY) per patient-year. The major cost driver for direct cost was stroke's acute hospitalization expense, which accounted for 61.5% (CNY 18,706.1). Among the seven patients not reaching the legal retirement age, the indirect cost per person-year totaled 16,838.9 CNY, most of which (63.0%) was a result of early retirement. The analysis also suggested that higher hospital ranking (based on the tier system), longer hospital stay, higher modified Rankin Scale score, taking surgery during hospitalization, receiving thrombolysis therapy, and incidence of complications such as pneumonia or cerebral edema predicted higher inpatient costs.
CONCLUSIONS: Hospital costs due to strokes among patients with AF are the predominant contributor to the total direct cost, which is consistent with current hospital-centered treatment pattern in China. However, literature suggested that AF-induced strokes are highly preventable with drugs and clinical procedures, which highlights the importance of optimal clinical management of stroke prevention in patients with AF.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; cost of illness; ischemic stroke

Year:  2013        PMID: 29702842     DOI: 10.1016/j.vhri.2013.02.008

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  5 in total

1.  A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.

Authors:  Steve Ryder; Kathleen Fox; Pratik Rane; Nigel Armstrong; Ching-Yun Wei; Sohan Deshpande; Lisa Stirk; Yi Qian; Jos Kleijnen
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

2.  In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.

Authors:  San-Shuai Chang; Jia-Hui Wu; Yi Liu; Ting Zhang; Xin Du; Jian-Zeng Dong; Gregory Y H Lip; Chang-Sheng Ma
Journal:  Chronic Dis Transl Med       Date:  2018-02-26

3.  The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis.

Authors:  Ariuntuya Tuvdendorj; Otgonjargal Dechinkhorloo; Bayarsaikhan Dorjsuren; Erik Buskens; Talitha Feenstra
Journal:  BMC Health Serv Res       Date:  2021-11-27       Impact factor: 2.655

4.  Medical Service Utilization and Direct Medical Cost of Stroke in Urban China.

Authors:  Dawei Zhu; Xuefeng Shi; Stephen Nicholas; Siyuan Chen; Ruoxi Ding; Lieyu Huang; Yong Ma; Ping He
Journal:  Int J Health Policy Manag       Date:  2022-03-01

5.  Analysis of hospitalization expenditures and influencing factors for inpatients with coronary heart disease in a tier-3 hospital in Xi'an, China: A retrospective study.

Authors:  Jing-Mei Ding; Xian-Zhi Zhang; Xue-Jun Hu; Huo-Liang Chen; Min Yu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.